Large-scale testing (Phase 3)Study completedNCT00304759What this trial is testingPROFIT - Prostate Fractionated Irradiation TrialWho this might be right forProstate Cancer Ontario Clinical Oncology Group (OCOG) 1,204
Testing effectiveness (Phase 2)Study completedNCT00547339What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer University of Texas Southwestern Medical Center 94
Not applicableLooking for participantsNCT03830788What this trial is testingErectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body RadiotherapyWho this might be right forProstate Cancer Center Eugene Marquis 240
Not applicableLooking for participantsNCT04945642What this trial is testingHigh Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaWho this might be right forProstate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8+5 more Jonsson Comprehensive Cancer Center 52
Large-scale testing (Phase 3)WithdrawnNCT03488810What this trial is testingApalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate CancerWho this might be right forProstate Cancer European Organisation for Research and Treatment of Cancer - EORTC
Not applicableActive Not RecruitingNCT07674225What this trial is testingDose-dEscalated MR-Guided Radiotherapy for Localized Prostate CancerWho this might be right forIntermediate Risk Prostate Cancer (Diagnosis)Prostate Cancer Sunnybrook Health Sciences Centre 24
Early research (Phase 1)Ended earlyNCT02875223What this trial is testingA Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's LymphomasWho this might be right forLymphoma, Non-HodgkinNeoplasms Celgene 75
Post-approval studies (Phase 4)Active Not RecruitingNCT06074510What this trial is testingPYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate CancerWho this might be right forProstate Cancer Lantheus Medical Imaging 274
Early research (Phase 1)Active Not RecruitingNCT05917860What this trial is testingNeoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate CancerWho this might be right forLocalized Prostate CarcinomaCastration-Naive Prostate CancerIntermediate Risk Prostate Cancer+1 more Turku University Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03412396What this trial is testingApalutamide in Treating Patients With Prostate Cancer Before Radical ProstatectomyWho this might be right forProstate AdenocarcinomaStage IIB Prostate Cancer AJCC v8 M.D. Anderson Cancer Center 45
Not applicableUnknownNCT02040610What this trial is testingHypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate CancerWho this might be right forProstate Cancer Provision Center for Proton Therapy 235
Not applicableActive Not RecruitingNCT01342367What this trial is testingFeasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerWho this might be right forProstate Cancer University of Chicago 74
Testing effectiveness (Phase 2)UnknownNCT02643511What this trial is testingHemiablative Focal Brachytherapy Pilot StudyWho this might be right forProstate Cancer St George Hospital, Australia 20
Testing effectiveness (Phase 2)Ended earlyNCT02140138What this trial is testingAn Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate CancerWho this might be right forProstate Carcinoma CureVac 35
Not applicableLooking for participantsNCT06518226What this trial is testingTwo-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate CancerWho this might be right forProstate CancerProstate AdenocarcinomaLocalized Prostate Carcinoma UMC Utrecht 160
Not applicableUnknownNCT02225262What this trial is testingA Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate TumorsWho this might be right forProstate CancerCancer of the ProstateProstate Neoplasm Community Cancer Center, Normal, Illinois 100
Not applicableStudy completedNCT02600156What this trial is testingFocal Laser Ablation of Low to Intermediate Prostate Cancer TumorsWho this might be right forProstate CancerProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more Mayo Clinic 7
Not applicableActive Not RecruitingNCT03426748What this trial is testingLDR vs. HDR Brachytherapy for Prostate CancerWho this might be right forProstate Cancer British Columbia Cancer Agency 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT05498272What this trial is testingStudy of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsWho this might be right forProstate CancerBRCA1 MutationBRCA2 Mutation+2 more Rana McKay, MD 32
Not applicableActive Not RecruitingNCT02339701What this trial is testingStereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate CancerWho this might be right forProstate Cancer Chinese University of Hong Kong 68